Maze Therapeutics, Inc. <MAZE.O>: Citigroup initiates coverage with buy rating; price target $50
MAZE•Related News
Cytosorbents Regains Compliance With Nasdaq Minimum Bid Price Requirement
CTSO•
General Mills Q1 Adjusted EPS USD 0.75 Vs. IBES Estimate USD 0.72
GIS•
Mosaic names Walt Precourt EVP of operations as Karen Swager plans retirement
MOS•
RPM to acquire Italy waterproofing solutions maker Volteco for Tremco unit
RPM•
Algorhythm - On Sept 21, Agreed To Terminate Settlement Agreement Covering $1.93 Million In Liabilities
RIME•